Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Training in Pancreatology and Biliary Diseases During Gastroenterology Residency: A National Survey by AEG-AESPANC.

Gastroenterologia y hepatologia·2026
Same author

Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design.

Alimentary pharmacology & therapeutics·2026
Same author

Multiple Correspondence Analysis reveals two different phenotypes of idiopathic chronic pancreatitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same author

Lactate Ringer's anti-inflammatory effects in acute pancreatitis are potentially mediated by protein lactylation of extracellular vesicles.

Scientific reports·2026
Same author

AEG-AESPANC-OPGE-SIED-SPG Ibero-Latin American Guidelines on Acute Pancreatitis (iLATAM-AP).

United European gastroenterology journal·2026
Same author

Heart Rate Variability as a Tell-tale Marker of Pain-related Autonomic Dysfunction in Chronic Pancreatitis.

Pancreas·2026

Related Experiment Video

Updated: May 8, 2026

Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis
06:05

Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis

Published on: January 27, 2023

[Fluid therapy in acute pancreatitis].

Enrique de-Madaria1

  • 1Unidad de Patología Pancreática, Hospital General Universitario de Alicante, Alicante, España.

Gastroenterologia Y Hepatologia
|August 31, 2013
PubMed
Summary

Aggressive fluid therapy for severe acute pancreatitis (AP) may not improve outcomes and could be harmful. Ringer's lactate may be beneficial, but further research is needed to guide fluid administration in AP patients.

Keywords:
Fluid therapyFluidoterapiaHumanosHumansIsotonic solutionsNecrotizing pancreatitisPancreatitisPancreatitis necrosantePancreatitis/fisiopatologíaPancreatitis/physiopathologyPancreatitis/tratamientoPancreatitis/treatmentSoluciones isotónicas

More Related Videos

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Related Experiment Videos

Last Updated: May 8, 2026

Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis
06:05

Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis

Published on: January 27, 2023

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Area of Science:

  • Gastroenterology
  • Critical Care Medicine

Context:

  • Severe acute pancreatitis (AP) historically warrants aggressive fluid resuscitation.
  • Guidelines recommend high fluid volumes due to fluid sequestration and potential hypotension.
  • Recent evidence challenges the universal benefit of aggressive fluid therapy.

Purpose:

  • To review the current evidence and guidelines for fluid therapy in acute pancreatitis.
  • To evaluate the potential benefits and harms of aggressive fluid administration.
  • To explore alternative fluid strategies, such as Ringer's lactate, and the role of hemodynamic monitoring.

Summary:

  • Aggressive fluid resuscitation in AP is based on older data and may be detrimental.
  • Ringer's lactate may offer a more favorable outcome than other crystalloids, requiring further investigation.
  • Hemodynamic monitoring is often unnecessary and unproven for improving AP prognosis.

Impact:

  • Challenges traditional fluid resuscitation protocols for AP.
  • Suggests a shift towards more individualized and potentially less aggressive fluid strategies.
  • Highlights the need for high-quality clinical trials to establish optimal fluid management in AP.